• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安慰剂——恨多于爱。

Placebo - More hatred than love.

作者信息

Zhang Hong-Liang

机构信息

Department of Neurology, The First Hospital of Jilin University, Changchun, China. Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.

出版信息

J Neurosci Rural Pract. 2011 Jan;2(1):105-7. doi: 10.4103/0976-3147.80089.

DOI:10.4103/0976-3147.80089
PMID:21716804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3122983/
Abstract

A placebo is a sham medical intervention that can produce a placebo effect. Laboratory evidence supports the existence of several mechanisms of placebo effects in both healthy population and patients with a variety of medical conditions. The ethics of placebos have long been debated. However, accumulating ethical concern has arisen from the worldwide use of placebo in randomized control trials (RCTs), which may render their participants without early and optimal treatment. Although the pilgrimage of placebo is still on the way, refinement of controls in RCTs is worth paying new attention to.

摘要

安慰剂是一种虚假的医学干预手段,可产生安慰剂效应。实验室证据支持在健康人群和患有各种疾病的患者中存在多种安慰剂效应机制。安慰剂的伦理问题长期以来一直存在争议。然而,由于安慰剂在全球范围内用于随机对照试验(RCT),引发了越来越多的伦理担忧,这可能会使试验参与者无法获得早期和最佳治疗。尽管安慰剂的使用仍在继续,但随机对照试验中对照方法的改进值得重新关注。

相似文献

1
Placebo - More hatred than love.安慰剂——恨多于爱。
J Neurosci Rural Pract. 2011 Jan;2(1):105-7. doi: 10.4103/0976-3147.80089.
2
The ethics of placebo-controlled trials: a comparison of inert and active placebo controls.安慰剂对照试验的伦理学:惰性安慰剂对照与活性安慰剂对照的比较
World J Surg. 2005 May;29(5):610-4. doi: 10.1007/s00268-005-7621-7.
3
Ethics, methodology and the use of placebo controls in surgical trials.外科试验中的伦理学、方法学及安慰剂对照的应用
Brain Res Bull. 2005 Oct 30;67(4):290-7. doi: 10.1016/j.brainresbull.2005.06.028.
4
Ocriplasmin for symptomatic vitreomacular adhesion.用于有症状性玻璃体黄斑粘连的奥克纤溶酶
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
5
Selecting a control for in vitro fertilization and acupuncture randomized controlled trials (RCTs): how sham controls may unnecessarily complicate the RCT evidence base.选择体外受精和针灸随机对照试验(RCT)的对照:假对照可能会不必要地使 RCT 证据基础复杂化。
Fertil Steril. 2011 Jun 30;95(8):2456-61. doi: 10.1016/j.fertnstert.2011.04.040. Epub 2011 May 13.
6
Ethical framework for the use of sham procedures in clinical trials.临床试验中使用假手术的伦理框架。
Crit Care Med. 2003 Mar;31(3 Suppl):S126-30. doi: 10.1097/01.CCM.0000054906.49187.67.
7
The Ethics of Placebo Effects in Clinical Practice and Research.安慰剂效应在临床实践和研究中的伦理问题。
Int Rev Neurobiol. 2018;139:463-484. doi: 10.1016/bs.irn.2018.07.031. Epub 2018 Aug 7.
8
Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.银屑病随机对照试验中使用安慰剂对照组的患病率及相关因素:一项横断面研究。
J Am Acad Dermatol. 2006 Nov;55(5):814-22. doi: 10.1016/j.jaad.2006.07.005. Epub 2006 Sep 14.
9
Biological, clinical, and ethical advances of placebo effects.安慰剂效应的生物学、临床和伦理进展。
Lancet. 2010 Feb 20;375(9715):686-95. doi: 10.1016/S0140-6736(09)61706-2.
10
What makes placebo-controlled trials unethical?安慰剂对照试验为何不道德?
Am J Bioeth. 2002 Spring;2(2):3-9. doi: 10.1162/152651602317533523.

本文引用的文献

1
Aspirin for primary prevention of cardiovascular events in people with diabetes.阿司匹林用于糖尿病患者心血管事件的一级预防。
J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86. doi: 10.1016/j.jacc.2010.04.003.
2
Biological, clinical, and ethical advances of placebo effects.安慰剂效应的生物学、临床和伦理进展。
Lancet. 2010 Feb 20;375(9715):686-95. doi: 10.1016/S0140-6736(09)61706-2.
3
Chuanxiong preparations for preventing stroke.用于预防中风的川芎制剂
Cochrane Database Syst Rev. 2010 Jan 20(1):CD006765. doi: 10.1002/14651858.CD006765.pub2.
4
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.一项口服芬戈莫德治疗复发性多发性硬化的安慰剂对照试验。
N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20.
5
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.急性缺血性卒中发病3.0 - 4.5小时后使用阿替普酶进行卒中治疗(ECASS III):一项随机对照试验的额外结局及亚组分析
Lancet Neurol. 2009 Dec;8(12):1095-102. doi: 10.1016/S1474-4422(09)70264-9. Epub 2009 Oct 21.
6
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.雷沙吉兰治疗帕金森病的双盲、延迟启动试验。
N Engl J Med. 2009 Sep 24;361(13):1268-78. doi: 10.1056/NEJMoa0809335.
7
Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.替罗非班预防有缺血性卒中或短暂性脑缺血发作病史患者缺血性起源的脑血管和心血管事件(PERFORM)研究的原理与设计
Cerebrovasc Dis. 2009;27 Suppl 3:28-32. doi: 10.1159/000209263. Epub 2009 May 14.
8
Multiple sclerosis: following clues from cause to cure.多发性硬化症:从病因到治愈的探索线索
Lancet Neurol. 2009 Jan;8(1):6-8. doi: 10.1016/S1474-4422(08)70272-2.
9
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.急性缺血性卒中发病3至4.5小时后使用阿替普酶进行溶栓治疗。
N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.
10
The power of context: reconceptualizing the placebo effect.情境的力量:重新认识安慰剂效应。
J R Soc Med. 2008 May;101(5):222-5. doi: 10.1258/jrsm.2008.070466.